ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma

Yu, Hongjun; Wang, Chaoqun; Ke, Shanjia; Bai, Miaoyu; Xu, Yanan; Lu, Shounan; Feng, Zhigang; Qian, Baolin; Xu, Yue; Zhou, Menghua; Li, Zihao; Yin, Bing; Li, Xinglong; Hua, Yongliang; Zhou, Yongzhi; Pan, Shangha; Fu, Yao*; Ma, Yong*哈尔滨医科大学; 1; y
Frontiers in Immunology2022-6-22DOI: 10.3389/fimmu.2022.892750
4被引4阅读
引用收藏
分享

摘要

BackgroundComplement factor H-related 4 (CFHR4) is a protein-coding gene that plays an essential role in multiple diseases. However, the prognostic value of CFHR4 in hepatocellular carcinoma (HCC) is unknown. MethodsUsing multiple databases, we investigated CFHR4 expression levels in HCC and multiple cancers. The relationship between CFHR4 expression levels and clinicopathological variables was further analyzed. Various potential biological functions and regulatory pathways of CFHR4 in HCC were identified by performing a Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Gene Set Enrichment Analysis (GSEA). Single-sample gene set enrichment analysis (ssGSEA) was performed to confirm the correlation between CFHR4 expression and immune cell infiltration. The correlations between CFHR4 expression levels in HCC and N6-methyladenosine (m6A) modifications and the competing endogenous RNA (ceRNA) regulatory networks were confirmed in TCGA cohort. ResultsCFHR4 expression levels were significantly decreased in HCC tissues. Low CFHR4 expression in HCC tissues was significantly correlated with the patients' sex, race, age, TNM stage, pathological stage, tumor status, residual tumor, histologic grade and alpha fetal protein (AFP) level. GO and KEGG analyses revealed that differentially expressed genes related to CFHR4 may be involved in the synaptic membrane, transmembrane transporter complex, gated channel activity, chemical carcinogenesis, retinol metabolism, calcium signaling pathway, PPAR signaling pathway, insulin and gastric acid secretion. GSEA revealed that the FCGR-activated reaction, PLK1 pathway, ATR pathway, MCM pathway, cascade reactions of PI3K and FGFR1, reactant-mediated MAPK activation and FOXM1 pathway were significantly enriched in HCC with low CFHR4 expression. Moreover, CFHR4 expression was inversely correlated the levels of infiltrating Th2 cells, NK CD56bright cells and Tfh cells. In contrast, we observed positive correlations with the levels of infiltrating DCs, neutrophils, Th17 cells and mast cells. CFHR4 expression showed a strong correlation with various immunomarker groups in HCC. In addition, high CFHR4 expression significantly prolonged the overall survival (OS), disease-specific survival (DSS) and progression-free interval (PFI). We observed a substantial correlation between the expression of CFHR4 and multiple N6-methyladenosine genes in HCC and constructed potential CFHR4-related ceRNA regulatory networks. ConclusionsCFHR4 might be a potential therapeutic target for improving the HCC prognosis and is closely related to immune cell infiltration.

学科与关键词

关键词
CFHR4prognosisbiomarkerimmune Infiltratehepatocellular carcinoma
相关
加载中…
  • Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma
    Wang, Haoran; He, Meng; Zhang, Zheng; Yin, Wenze; Ren, Bixuan; Lin, Yujia*Journal of Oncology, 2022, 2022: 1752827.被引 1
  • Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment
    Yin, Zi*; Ma, Tingting; Chen, Sheng; Yu, Min*Cancer Biomarkers, 2023, 36(3): 231-250.被引 1
  • Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
    Xiao, Siyu; Huang, Shanzhou; Yang, Jie*OncoTargets and Therapy, 2020, 13: 11607-11619.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-06-22
卷期
第 13 卷
页码
892750
DOI
10.3389/fimmu.2022.892750
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Research Fund of the National Natural Scientific Foundation of China [81100305, 81470876, 81270527]; Natural Science Foundation of Heilongjiang Province of China [QC2013C094, LC2018037]; Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province [CXPJJH11900001-2019349]; Outstanding Youth Training Fund from Academician Yu Weihan of Harbin Medical University; First Affiliated Hospital of Harbin Medical University [2019L01, HYD2020JQ0007]

作者

  • Y

    Yu, Hongjun (第一作者)

    1 · harbin med univ

  • W

    Wang, Chaoqun

    1 · harbin med univ

查看全部 18 位作者收起作者
  • K

    Ke, Shanjia

    1 · harbin med univ

  • B

    Bai, Miaoyu

    1 · harbin med univ

  • X

    Xu, Yanan

    1 · harbin med univ

  • L

    Lu, Shounan

    1 · harbin med univ

  • F

    Feng, Zhigang

    1 · harbin med univ

  • Q

    Qian, Baolin

    1 · harbin med univ

  • X

    Xu, Yue

    peoples liberat army gen hosp

  • Z

    Zhou, Menghua

    1 · harbin med univ

  • L

    Li, Zihao

    1 · harbin med univ

  • Y

    Yin, Bing

    1 · harbin med univ

  • L

    Li, Xinglong

    1 · harbin med univ

  • H

    Hua, Yongliang

    1 · harbin med univ

  • Z

    Zhou, Yongzhi

    1 · harbin med univ

  • P

    Pan, Shangha

    1 · harbin med univ

  • F

    Fu, Yao (通讯)

    1 · harbin med univ

  • M

    Ma, Yong (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417